PTGX May 2024 30.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:19AM EDT. Market open.
| Previous Close | 0.2500 |
| Open | 1.0000 |
| Bid | 0.0000 |
| Ask | 2.7000 |
| Strike | 30.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.6500 - 1.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 36 |
ACCESSWIREProtagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
NEWARK, CA / ACCESSWIRE / May 14, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that additional data from the rusfertide Phase 2 REVIVE open label extension study will be the focus of an oral ...
GuruFocus.comProtagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
- ACCESSWIRE
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital One 1st Annual Biotech/Biopharma Disruptors Event
NEWARK, CA / ACCESSWIRE / May 7, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and investor ...
© 2024 Yahoo. All rights reserved.